Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2025-12-25 @ 4:52 PM
Study NCT ID:
NCT04989803
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2021-07-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
Sponsor:
Kite, A Gilead Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-26
First Submit QC Date:
None
Study First Post Date:
2021-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-11-18
Last Update Post Date Type:
ESTIMATED